Skip to main content
. Author manuscript; available in PMC: 2015 Feb 12.
Published in final edited form as: Genet Epidemiol. 2014 Sep;38(0 1):S37–S43. doi: 10.1002/gepi.21823

Table 1.

Summary of real data analyzed.

Contribution Phenotypes Genotypes Covariates Medication Longitudinal Variants Scope
Balliu et al. [2014] DBP dose, geno Age, smoke unadjusted longitudinal all Chromosome 3 with excess IBD
Chen et al. [2014] rSBP, DBP dose Age, sex, smoke excluded baseline: first non-missing MAF < 5% genome
Hailine et al. [2014] HTN dose None unadjusted any(HTN) all genome
He and Pitkäniemi [2014] log(SBP) dose Age unadjusted max(SBP) MAF < 1% genome
Lacey et al. [2014] SBP dose, gwas Age, sex, smoke excluded baseline: time1 MAF > 1% genome
Li et al. [2014] SBP dose Age, sex unadjusted baseline: first non-missing all genome
Liu et al. [2014] HTN dose Age, smoke adjusted longitudinal all Chromosome 3
Malzahn et al. [2014] rSBP dose, gwas Age, sex, age×sex excluded baseline: time1 all Five genes on Chromosome 3
Zhang and Pan [2014] HTN, SBP geno Age, sex, smoke unadjusted baseline: time1 MAF > 5% 6,228 common variants

DBP, diastolic blood pressure; HTN, hypertension; IBD, identity-by-descent; MAF, minor allele frequency; rSBP, rank-transformed SBP; SBP, systolic blood pressure.